Related Experiment Video
Updated: Jul 16, 2026
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Tech.Sight. Gene therapy. Hurdles and hopes for cancer treatment
Kelly K Hunt1, Stephan A Vorburger
1Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. khunt@mdanderson.org
Abstract:
Remarkable progress has been achieved in the field of gene therapy over the past decade. The initial excitement in this young field has led to the development of more than 500 gene therapy protocols approved for evaluation in clinical trials. As these clinical trials progress, many obstacles have been identified that investigators in the field will need to overcome. Among the most important areas of investigation in the field of cancer gene therapy are 1) development of novel vectors to improve gene delivery, 2) development of tumor-selective binding to improve specific tumor targeting, and 3) improvement of the therapeutic window to reduce the toxicity of gene therapy administered alone or in combination with conventional agents. The challenge is not to replace current strategies for cancer therapy with gene therapy but to incorporate gene therapy as a more rational, molecularly based approach to increase our therapeutic armamentarium.
Insights
Gene therapy shows promise for cancer treatment, with over 500 clinical trials underway. Key challenges include improving gene delivery, tumor targeting, and reducing toxicity for better cancer gene therapy outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Gene therapy has seen significant advancements in the last decade, with over 500 gene therapy protocols entering clinical trials.
- Despite progress, clinical trials have revealed several obstacles that need to be addressed for effective cancer gene therapy.
Purpose of the Study:
- To outline critical areas for advancing cancer gene therapy.
- To discuss strategies for improving gene delivery, tumor targeting, and therapeutic window.
- To position gene therapy as a complementary approach within the broader cancer treatment landscape.
Main Methods:
- Focus on the development of novel vectors for enhanced gene delivery.
- Investigation into tumor-selective binding agents for precise cancer targeting.
- Strategies to optimize the therapeutic window, minimizing toxicity in combination therapies.
Main Results:
- Identification of key challenges in current gene therapy clinical trials.
- Highlighting the need for improved vectors, targeting mechanisms, and toxicity management.
- Emphasizing the integration of gene therapy with conventional treatments.
Conclusions:
- Cancer gene therapy requires further research into vector development, tumor specificity, and safety profiles.
- Gene therapy should be viewed as an adjunct to, not a replacement for, existing cancer treatments.
- The goal is to enhance the therapeutic armamentarium with rational, molecularly-guided gene therapy approaches.
Related Concept Videos
02:18Cancer
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers